Predictors of clinical outcomes of resected ampullary adenocarcinoma: A single-institution experience

European Journal of Surgical Oncology

Volumn 37, Issue 9, 2011, Pages 791-797

  Lazaryan, A ^a   Kalmadi, S ^a   Almhanna, K ^a   Pelley, R ^a   Kim, R ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Ampulla of Vater; Clinical outcomes; Risk factors

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 80051670174     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.06.008     Document Type: Article

References (27)

1. C.J. Yeo, J.L. Cameron, and K.D. Lillemoe Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 221 6 1995 731 733 721-31; discussion
2. J.M. Winter, J.L. Cameron, and K. Olino Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis J Gastrointest Surg 14 2 2010 379 387
3. J.H. Allema, M.E. Reinders, and T.M. van Gulik Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region Cancer 75 8 1995 2069 2076
4. S. Bhatia, R.C. Miller, M.G. Haddock, J.H. Donohue, and S. Krishnan Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience Int J Radiat Oncol Biol Phys 66 2 2006 514 519 (Pubitemid 44332725)
5. R.D. Kim, P.S. Kundhal, and I.D. McGilvray Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma J Am Coll Surg 202 1 2006 112 119 (Pubitemid 41831481)
6. J.P. Duffy, O.J. Hines, and J.H. Liu Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections Arch Surg 138 9 2003 948 950 941-8; discussion
7. T. Todoroki, N. Koike, and Y. Morishita Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater Ann Surg Oncol 10 10 2003 1176 1183 (Pubitemid 40486813)
8. Q.L. Qiao, Y.G. Zhao, and M.L. Ye Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection World J Surg 31 1 2007 144 146 137-43; discussion
9. N.P. Jarufe, C. Coldham, A.D. Mayer, D.F. Mirza, J.A. Buckels, and S.R. Bramhall Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region Dig Surg 21 3 2004 202 209 (Pubitemid 39070131)
10. A. Dorandeu, J.L. Raoul, and F. Siriser Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases Gut 40 3 1997 350 355 (Pubitemid 27145648)
11. M.A. Talamini, R.C. Moesinger, and H.A. Pitt Adenocarcinoma of the ampulla of Vater. A 28-year experience Ann Surg 225 5 1997 599 600 590-9; discussion
12. H.P. Hsu, T.M. Yang, Y.H. Hsieh, Y.S. Shan, and P.W. Lin Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer Ann Surg Oncol 14 1 2007 50 60
13. S.M. Woo, J.K. Ryu, and S.H. Lee Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma Ann Surg Oncol 14 11 2007 3195 3201 (Pubitemid 47594288)
14. S. Krishnan, V. Rana, and D.B. Evans Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater Int J Radiat Oncol Biol Phys 70 3 2008 735 743 (Pubitemid 351199709)
15. C. Chan, M.F. Herrera, and L. de la Garza Clinical behavior and prognostic factors of periampullary adenocarcinoma Ann Surg 222 5 1995 632 637
16. K. Yamaguchi, and K. Nishihara Long- and short-term survivors after pancreatoduodenectomy for ampullary carcinoma J Surg Oncol 50 3 1992 195 200
17. I. Hatzaras, N. George, P. Muscarella, W.S. Melvin, E.C. Ellison, and M. Bloomston Predictors of survival in periampullary cancers following pancreaticoduodenectomy Ann Surg Oncol 17 4 2010 991 997
18. I. Hirai, W. Kimura, and K. Ozawa Perineural invasion in pancreatic cancer Pancreas 24 1 2002 15 25 (Pubitemid 34019655)
19. J. Herman, C. Hsu, and J. Zhou Benefit of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins hospital - Mayo Clinic Collaborative study J Radiat OncologyBiologyPhysics 72 Suppl. 1 2008 S126
20. R.M. Barton, and E.M. Copeland 3rd Carcinoma of the ampulla of Vater Surg Gynecol Obstet 156 3 1983 297 301 (Pubitemid 13148015)
21. T.A. Splinter, H. Obertop, T.C. Kok, and J. Jeekel Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study J Cancer Res Clin Oncol 115 2 1989 200 202 (Pubitemid 19109381)
22. J.H. Lee, R. Whittington, and N.N. Williams Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas Int J Radiat Oncol Biol Phys 47 4 2000 945 953 (Pubitemid 30345592)
23. J. Zhou, C.C. Hsu, and J.M. Winter Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater Radiother Oncol 92 2 2009 244 248
24. R. Kim, R. Tsao, and A. Tan A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators J Gastrointest Surg 14 7 2010 1159 1169
25. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial Jama-Journal Am Med Assoc 297 3 2007 267 277 (Pubitemid 46143304)
26. W.F. Regine Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial (vol 299, pg 1019, 2008) Jama-Journal Am Med Assoc 299 16 2008 1902-1902
27. D. Santini, G. Perrone, and B. Vincenzi Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer Ann Oncol 19 4 2008 724 728 (Pubitemid 351461043)